Looking into the current session, Edwards Lifesciences Inc. (NYSE:EW) shares are trading at $71.65, after a 0.28% spike. Moreover, over the past month, the stock spiked by 0.45%, but in the past year, fell by 15.81%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session.

A Look at Edwards Lifesciences P/E Relative to Its Competitors

The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future.

Edwards Lifesciences has a lower P/E than the aggregate P/E of 85.67 of the Health Care Equipment & Supplies industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued.